Sorry, your browser is out of date. To view this page correctly, please install a modern browser (Microsoft Edge, Firefox or Google Chrome).
SAI - Detailed view
Please log in as a company employee using your Swiss-Rx-Login. For further information please see the FAQ.
XOFIGO Inj Lös 6600 kBq/6ml Vial 6 ml
Drug
Xofigo, Injektionslösung
Symptomatische Knochenmetastasen bei kastrationsresistentem Prostatakarzinom
17.02. – radiotherapeuticals
HAM – Human medicine
LSPA – Parenteral solution
R – radiopharmaceutic products
A – Dispensed once only on prescription by a physician or veterinarian (A)
Z – approved
8/29/2014
12/31/9999
Dosage strength
Xofigo 1100 kBq/ml Ra-223-Dichlorid, Injektionslösung
Symptomatische Knochenmetastasen bei kastrationsresistentem Prostatakarzinom
01
Z – approved
Package
7680627320014
No information made available
A/R – Authorised / referenced
1 vial(s)
001
Z – approved
Declaration
Component
6600 kBq radii(223-Ra) dichloridum
natrii chloridum
natrii citras dihydricus
acidum hydrochloridum
aqua ad iniectabile
26.4 mg natrium
natrii citras dihydricus
acidum hydrochloridum
aqua ad iniectabile
26.4 mg natrium
Spezialitätenliste***
SL
-
-
5276.80
None
Yes
10%
No
Authorisation holder
7601001002593
Bayer (Schweiz) AG
Uetlibergstrasse 132
8045 Zürich (ZH)
Uetlibergstrasse 132
8045 Zürich (ZH)
Date of revision of the text
7/4/2024
Please log in as a company employee using your Swiss-Rx-Login. For further information please see the FAQ.
Data source: Swissmedic, *authorisation holder, **Refdata foundation, ***FOPH.